A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with kidney inflammation due to ANCA-associated vasculitis (AAV) have a high incidence of venous thromboembolism or VTE,…
Adding plasma exchange to immune-suppressing treatment does not significantly improve clinical outcomes in people with ANCA-associated vasculitis (AAV),…
ANCA-associated vasculitis (AAV) carries high healthcare costs for therapies and hospitalizations to treat the disease itself and related infections,…
Muscle biopsies could be used to diagnose ANCA-associated vasculitis (AAV), a new study indicates. The finding suggests that such…
Extracellular vesicles, or the tiny membrane-bound particles that are released from cells, could be used as a blood biomarker of…
The complement system, a part of the immune system, is overactive in people with active ANCA-associated vasculitis (AAV),…
The presence of detectable ANCA antibodies and B-cells after initial treatment with rituximab — used to induce…
The complement system, a component of the immune system, is overactive in people with necrotizing glomerulonephritis, or inflammation…
Fingolimod (FTY720), a medication used to treat multiple sclerosis, also appears to ease many of the symptoms of…